Locations
San Diego, CA, USA
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Series C+
founded in
2009
NanoCellect Biomedical, Inc. aims to make flow cytometry and cell sorting technology more affordable and accessible for life science researchers to perform cellular analysis, develop molecular diagnostics, and improve personalized medicine. A critical element for biomedical research is the ability for scientists to analyze and isolate cells using flow cytometers. Scientists use flow cytometers to obtain a fast, objective and quantitative recording of fluorescent signals from individual cells as well as physical separation of cells of particular interest. NanoCellect's mission is to facilitate breakthrough biomedical discoveries by making cell analysis and sorting technology more portable, affordable, and easier to use. We use microfluidics to make flow cytometers that enable biomedical scientists to analyze and sort cells required for drug discovery, diagnostics, or basic research.
Something looks off?